<!doctype html>
<html lang="en-GB">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Bacterial Vaginosis (BV) â€” Oneâ€‘Page Clinical Algorithm</title>
  <style>
    /* --------- Design tokens --------- */
    :root {
      --bg: #0b1020;
      --bg-muted: #121830;
      --card: #0f1630;
      --ink: #eaf0ff;
      --ink-dim: #bec7e6;
      --brand: #6aa3ff;
      --brand-2: #8bd6ff;
      --ok: #41c29b;
      --warn: #ffb84d;
      --danger: #ff6b6b;
      --chip: rgba(138, 180, 255, 0.12);
      --shadow: 0 10px 30px rgba(0,0,0,.35);
      --radius: 18px;
      --radius-sm: 12px;
      --radius-lg: 26px;
    }

    @media (prefers-color-scheme: light) {
      :root {
        --bg: #f7f9fc;
        --bg-muted: #eef3ff;
        --card: #ffffff;
        --ink: #0d1b3a;
        --ink-dim: #4b5b7a;
        --brand: #2b6fff;
        --brand-2: #00b3ff;
        --chip: rgba(43, 111, 255, 0.10);
        --shadow: 0 14px 28px rgba(13,27,58,.08), 0 10px 10px rgba(13,27,58,.04);
      }
    }

    html, body { height: 100%; }
    body {
      margin: 0;
      font: 15px/1.55 system-ui, -apple-system, Segoe UI, Roboto, Ubuntu, Cantarell, Noto Sans, "Helvetica Neue", Arial, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol";
      color: var(--ink);
      background: radial-gradient(1200px 600px at 10% -10%, rgba(106,163,255,.16), transparent 50%),
                  radial-gradient(1200px 800px at 110% 0%, rgba(0,179,255,.18), transparent 45%),
                  var(--bg);
    }
    .wrap { max-width: 1100px; margin: 0 auto; padding: 28px 20px 64px; }

    /* --------- Header --------- */
    header.hero {
      position: relative; overflow: hidden;
      background: linear-gradient(135deg, rgba(106,163,255,.18), rgba(0,179,255,.12));
      border: 1px solid rgba(138, 180, 255, .25);
      border-radius: var(--radius-lg);
      padding: 26px 22px 20px; margin-bottom: 18px;
      box-shadow: var(--shadow);
    }
    .hero h1 { font-size: clamp(22px, 3.4vw, 34px); margin: 0 0 8px; letter-spacing: .2px; }
    .hero p.sub { margin: 0; color: var(--ink-dim); }
    .badge-row { display: flex; flex-wrap: wrap; gap: 8px; margin-top: 14px; }
    .badge { display: inline-flex; align-items: center; gap: 8px; padding: 8px 12px; border-radius: 999px; background: var(--chip); color: var(--ink); border: 1px solid rgba(138, 180, 255, .25); }
    .badge svg { width: 16px; height: 16px; opacity: .9; }

    .hero-actions { display: flex; gap: 10px; align-items: center; margin-top: 16px; flex-wrap: wrap; }
    .btn { border: 1px solid rgba(138,180,255,.38); background: linear-gradient(180deg, rgba(255,255,255,.05), rgba(255,255,255,.02)); color: var(--ink); padding: 10px 14px; border-radius: 12px; cursor: pointer; transition: transform .05s ease, box-shadow .2s ease; box-shadow: var(--shadow); }
    .btn:hover { transform: translateY(-1px); }
    .btn:active { transform: translateY(0); }

    /* --------- Layout --------- */
    .grid { display: grid; grid-template-columns: 1.15fr .85fr; gap: 18px; align-items: start; }
    @media (max-width: 950px) { .grid { grid-template-columns: 1fr; } }

    .card { background: var(--card); border: 1px solid rgba(138, 180, 255, .18); border-radius: var(--radius); padding: 18px; box-shadow: var(--shadow); }
    .card h2 { margin: 0 0 12px; font-size: 18px; letter-spacing: .2px; }
    .card h3 { margin: 18px 0 6px; font-size: 15px; opacity: .9; }
    .muted { color: var(--ink-dim); }
    .pill { display:inline-block; font-weight:600; background: var(--chip); border:1px solid rgba(138,180,255,.2); padding:3px 9px; border-radius:999px; margin-right:6px; }

    ul.clean, ol.clean { margin: 8px 0 0 0; padding-left: 18px; }
    li + li { margin-top: 4px; }

    /* --------- Flowchart --------- */
    .flow { display: grid; gap: 12px; }
    .step { position: relative; counter-increment: s; padding: 14px 14px 14px 48px; background: var(--card); border: 1px solid rgba(138,180,255,.22); border-radius: var(--radius); box-shadow: var(--shadow); }
    .step::before { content: counter(s); position: absolute; left: 12px; top: 12px; width: 28px; height: 28px; border-radius: 8px; display:grid; place-items:center; font-weight: 700; background: linear-gradient(135deg, var(--brand), var(--brand-2)); color: #fff; box-shadow: 0 6px 14px rgba(0,0,0,.25); }
    .step + .step::after { content: ""; position: absolute; left: 26px; top: -12px; width: 2px; height: 12px; background: linear-gradient(to bottom, rgba(138,180,255,.0), rgba(138,180,255,.5)); }
    .step h3 { margin: 0 0 8px; font-size: 15px; letter-spacing: .2px; }

    .callout { border-left: 4px solid var(--brand); padding-left: 12px; }
    .callout.warn { border-color: var(--warn); }
    .callout.danger { border-color: var(--danger); }

    .grid-2 { display: grid; grid-template-columns: 1fr 1fr; gap: 12px; }
    @media (max-width: 700px) { .grid-2 { grid-template-columns: 1fr; } }

    table { width: 100%; border-collapse: collapse; }
    th, td { padding: 10px 8px; border-bottom: 1px dashed rgba(138,180,255,.25); vertical-align: top; }
    th { text-align: left; font-size: 13px; color: var(--ink-dim); font-weight:600; }
    td strong { font-weight: 700; }

    .footer { margin-top: 14px; font-size: 12px; color: var(--ink-dim); }

    /* Print */
    @media print {
      body { background: #fff; color: #000; }
      header.hero { background: none; border: 0; box-shadow: none; }
      .btn, .badge-row { display: none !important; }
      .card, .step { box-shadow: none; border-color: #ddd; }
      :root { --ink: #000; --ink-dim: #333; --card: #fff; }
    }
  </style>
</head>
<body>
  <div class="wrap">

    <header class="hero">
      <h1>Bacterial Vaginosis (BV) â€” Oneâ€‘Page Clinical Algorithm</h1>
      <p class="sub">Fast reference for primary care consultations â€¢ Last revised in source: <strong>JulyÂ 2023</strong></p>
      <div class="badge-row" aria-label="Quick facts">
        <span class="badge" title="Typical symptoms">
          <!-- nose icon -->
          <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><path d="M9 9c0-3 2-5 3-5s3 2 3 5c0 2 1 3 3 4-1 2-3 3-6 3s-5-1-6-3c2-1 3-2 3-4Z"/></svg>
          Thin, fishy discharge; often no itch
        </span>
        <span class="badge" title="pH clue">
          <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><path d="M3 3h18v18H3z"/><path d="M7 16h10M7 12h10M7 8h4"/></svg>
          Vaginal pHÂ &gt;Â 4.5 supports Dx
        </span>
        <span class="badge" title="Not an STI">
          <svg viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" aria-hidden="true"><circle cx="12" cy="12" r="10"/><path d="m4.9 19.1 14.2-14.2"/></svg>
          Sexually associated, not classed STI
        </span>
      </div>
      <div class="hero-actions">
        <button class="btn" onclick="window.print()">ğŸ–¨ï¸Â Print / Save PDF</button>
        <button class="btn" id="toggleTheme" aria-pressed="false">ğŸŒ—Â Toggle theme</button>
      </div>
    </header>

    <main class="grid" aria-label="BV quick algorithm and prescribing">
      <!-- Left: Algorithm -->
      <section class="card" aria-label="Decision pathway">
        <h2>Decision Pathway</h2>
        <div class="flow">
          <article class="step">
            <h3>1) Presentation</h3>
            <ul class="clean">
              <li>Thin, homogenous grey/white discharge with fishy odour; ~50% asymptomatic.</li>
              <li class="muted">If itch/soreness prominent or features atypical â†’ consider other causes (Candida, Trichomonas, chlamydia, gonorrhoea, HSV), mixed infection, foreign body, atrophic/physiological discharge, malignancy.</li>
            </ul>
          </article>

          <article class="step">
            <h3>2) Assessment</h3>
            <div class="grid-2">
              <div>
                <h3>History &amp; risk</h3>
                <ul class="clean">
                  <li>Onset, triggers (postâ€‘sex/menstruation), recurrence.</li>
                  <li>Risk factors: douching, smoking, new/multiple partners, copper IUD; condom use may be protective.</li>
                </ul>
              </div>
              <div>
                <h3>Examination &amp; tests</h3>
                <ul class="clean">
                  <li>Speculum if indicated; take lateral vaginal wall swab.</li>
                  <li><strong>pH &gt;Â 4.5</strong> supports BV; if doubt, send for Gram stain/microscopy.</li>
                  <li>If high STI risk, test for chlamydia, gonorrhoea, trichomonas; offer HIV/syphilis serology.</li>
                </ul>
              </div>
            </div>
            <p class="muted">HVS culture not routinely required unless pregnant/postnatal/recent gynae procedures or upperâ€‘tract concern.</p>
          </article>

          <article class="step">
            <h3>3) Diagnosis</h3>
            <div class="callout">
              Typical Hx + appearance and <strong>pHÂ &gt;Â 4.5</strong> â†’ treat empirically. If atypical/uncertain â†’ microscopy Â± STI screen.
            </div>
          </article>

          <article class="step">
            <h3>4) Management â€” <span class="pill">Not pregnant</span></h3>
            <div class="grid-2">
              <div>
                <h3>Asymptomatic</h3>
                <ul class="clean">
                  <li>No treatment (except preâ€‘procedure/termination).</li>
                </ul>
                <h3>Symptomatic â€” firstâ€‘line</h3>
                <ul class="clean">
                  <li><strong>Metronidazole 400Â mg PO twice daily Ã—Â 5â€“7Â days</strong>.</li>
                  <li>If adherence issues: <strong>Metronidazole 2Â g PO single dose</strong> (not in pregnancy).</li>
                </ul>
              </div>
              <div>
                <h3>If oral not tolerated / preference</h3>
                <ul class="clean">
                  <li>Metronidazole 0.75% intravaginal gel OD Ã—Â 5Â days.</li>
                  <li>Clindamycin 2% intravaginal cream OD Ã—Â 7Â days.</li>
                  <li>Alternatives (less preferred): oral clindamycin; oral tinidazole.</li>
                </ul>
                <p class="muted">Test of cure not needed if symptoms resolve.</p>
              </div>
            </div>
          </article>

          <article class="step">
            <h3>5) Management â€” <span class="pill">Pregnant</span></h3>
            <ul class="clean">
              <li>No routine screening (except preâ€‘termination).</li>
              <li>Asymptomatic: discuss with obstetrician whether to treat.</li>
              <li>Symptomatic: <strong>Metronidazole 400Â mg PO twice daily Ã—Â 5â€“7Â days</strong>.<br><span class="muted">Avoid 2Â g singleâ€‘dose regimens.</span></li>
              <li>If oral unsuitable: metronidazole 0.75% gel OD Ã—Â 5Â days; clindamycin 2% cream OD Ã—Â 7Â days (2nd/3rd trimester only).</li>
              <li>Consider reâ€‘test in 1Â month if still symptomatic or if treated to reduce preterm birth risk.</li>
            </ul>
          </article>

          <article class="step">
            <h3>6) Persistent / Recurrent BV</h3>
            <ul class="clean">
              <li>Check adherence; reconfirm Dx (speculum, pH, microscopy).</li>
              <li>Address factors: douching, smoking; consider <strong>removing copper IUD</strong> if contributory.</li>
              <li>Switch regimen (e.g., 7â€‘day oral metronidazole if topical/2Â g stat used previously).</li>
              <li>Frequent recurrences despite adequate management â†’ consider <strong>metronidazole vaginal gel suppressive</strong> therapy (offâ€‘label) if experienced, or seek Gynae/GUM advice.</li>
              <li>Partner treatment: routine screening/treatment of <strong>male partners not indicated</strong>; consider testing/treating symptomatic female partners.</li>
            </ul>
          </article>

          <article class="step">
            <h3>7) Bottom line</h3>
            <div class="callout">
              Typical BV â†’ <strong>Metronidazole 400Â mg PO BD Ã—Â 5â€“7Â days</strong> (preferred). Pregnancy: treat only if symptomatic; avoid singleâ€‘dose regimens. Recurrent: reassess, switch regimen, address IUD/risk factors; consider suppressive gel with specialist input.
            </div>
          </article>
        </div>
      </section>

      <!-- Right: Quick reference cards -->
      <aside class="stack">
        <section class="card" aria-label="Quick prescribing guide">
          <h2>Quick Prescribing</h2>
          <table aria-label="Drug choices and notes">
            <thead>
              <tr><th>Option</th><th>Regimen</th><th>Notes</th></tr>
            </thead>
            <tbody>
              <tr>
                <td><strong>Metronidazole (oral)</strong></td>
                <td>400Â mg twice daily Ã—Â 5â€“7Â days</td>
                <td>Firstâ€‘line. Warn about possible alcohol reaction; avoid alcohol during course and for 48Â h after. Watch interactions (warfarin â†‘INR, lithium, ciclosporin, phenytoin). QT prolongation rare.</td>
              </tr>
              <tr>
                <td><strong>Metronidazole (oral)</strong></td>
                <td>2Â g single dose</td>
                <td>Only if adherence concerns; <em>do not</em> use in pregnancy.</td>
              </tr>
              <tr>
                <td><strong>Metronidazole gel 0.75%</strong></td>
                <td>1 applicator intravaginal OD Ã—Â 5Â days</td>
                <td>Avoid during menstruation; intercourse best avoided during treatment.</td>
              </tr>
              <tr>
                <td><strong>Clindamycin creamÂ 2%</strong></td>
                <td>1 applicator intravaginal OD Ã—Â 7Â days</td>
                <td>2nd/3rd trimester only if pregnant. May weaken condoms/diaphragms during use and for 5Â days after.</td>
              </tr>
              <tr>
                <td><strong>Alternatives</strong></td>
                <td>Oral clindamycin; oral tinidazole</td>
                <td>Less preferred.</td>
              </tr>
            </tbody>
          </table>
        </section>

        <section class="card" aria-label="Safety and red flags">
          <h2>Safety &amp; Prescribing Notes</h2>
          <ul class="clean">
            <li><strong>Alcohol:</strong> possible disulfiramâ€‘like reaction with oral metronidazole â€” avoid alcohol during treatment and for 48Â h after.</li>
            <li><strong>Interactions (oral metro):</strong> warfarin/acenocoumarol â†‘ anticoagulant effect (monitor INR); lithium â†‘ levels (monitor); ciclosporin â†‘ levels (monitor); phenytoin/phenobarbital alter metabolism; rare QT prolongation.</li>
            <li><strong>Clindamycin cream:</strong> oilâ€‘based â€” weakens condoms/diaphragms during use and for 5Â days after; pseudomembranous colitis rare; consider pregnancy/breastfeeding cautions.</li>
            <li><strong>Metronidazole gel:</strong> avoid during menstruation; candidiasis may worsen; intercourse best avoided during treatment.</li>
          </ul>
        </section>

        <section class="card" aria-label="STI and differentials">
          <h2>STI Screen &amp; Differentials</h2>
          <h3>When to test for STI</h3>
          <ul class="clean">
            <li>Highâ€‘risk women: test for <em>Chlamydia</em>, <em>Gonorrhoea</em>, <em>Trichomonas</em>; offer HIV &amp; syphilis serology.</li>
            <li>Offer annual chlamydia screening to sexually active &lt;25Â yrs or on partner change.</li>
          </ul>
          <h3>Key differentials</h3>
          <ul class="clean">
            <li>Candida (itch, curdy white, odourless).</li>
            <li>Trichomonas (yellow/green, frothy, fishy smell, irritation/dysuria).</li>
            <li>Chlamydia (often asymptomatic; purulent/mucopurulent discharge; pH â‰¤Â 4.5).</li>
            <li>Gonorrhoea (purulent cervical discharge, pain; itch uncommon).</li>
            <li>HSV (ulcers, severe pain; discharge uncommon).</li>
            <li>Physiological discharge, atrophic vaginitis, foreign body, cervical ectopy/polyps, malignancy, allergy, mechanical irritation.</li>
          </ul>
        </section>

        <section class="card" aria-label="Clinic tips">
          <h2>Clinic Tips</h2>
          <ul class="clean">
            <li>Swab lateral vaginal wall for pH (use narrowâ€‘range 3.8â€“5.5 paper). Avoid cervix/posterior fornix for pH.</li>
            <li>Selfâ€‘taken low vaginal swab acceptable if speculum declined.</li>
            <li>HVS culture not routine; reserve for pregnancy/postnatal/recent gynae procedures or upperâ€‘tract concern.</li>
            <li>Recurrence is common; set expectations and reinforce avoidance of douching and smoking cessation.</li>
          </ul>
        </section>
      </aside>
    </main>

    <p class="footer">Designed for rapid reference at point of care. Adapted from your provided guidance (NICE CKS: Bacterial vaginosis, last revised JulyÂ 2023). This oneâ€‘pager does not replace clinical judgement or local policies.</p>
  </div>

  <script>
    // Simple theme toggle with localStorage persistence
    const btn = document.getElementById('toggleTheme');
    const k = 'bv-theme';
    const apply = (t) => {
      if (!t) return;
      document.documentElement.setAttribute('data-theme', t);
      document.body.style.background = t === 'light' ? '#f7f9fc' : '';
      btn && (btn.setAttribute('aria-pressed', String(t === 'dark')));
    };
    const saved = localStorage.getItem(k);
    if (saved) apply(saved);
    btn && btn.addEventListener('click', () => {
      const current = document.documentElement.getAttribute('data-theme');
      const next = current === 'dark' ? 'light' : 'dark';
      localStorage.setItem(k, next);
      apply(next);
    });
  </script>
</body>
</html>